Statistical power in clinical trials
In a new debate published in BMC Medicine, Peter Bachetti talks about the concept of statistical power in determining sample size, the undue weight that is… Read more »
Latest posts by Robin Cassady-Cain (see all)
- New thematic series on clinical biomarkers in BMC Medicine - 5th October 2011
- Treating severe asthma: New minireview in BMC Medicine - 6th September 2011
- Epidemiology of major depression: Global patterns - 26th July 2011
The right to adequate pain treatment-new debate in BMC Medicine
In the developed world, we generally tend to take pain treatment and management for granted; if we’re in physical pain, someone will provide treatment to do… Read more »
Using Insulin-like growth factor genes to predict outcome in breast and lung cancer patients
As the era of personalised medicine and genomics evolves and the potential for better targeted treatments becomes a reality, the need to identify which… Read more »
Multiple sclerosis-new Minireview in BMC Medicine
If you’re like me, you probably know at least one person affected by multiple sclerosis, an autoimmune demyelinating disease of the central nervous system… Read more »
Multiple sclerosis-new Minireview in BMC Medicine
If you’re like me, you probably know at least one person affected by multiple sclerosis, an autoimmune demyelinating disease of the central nervous system… Read more »
Getting into a rhythm – What are the most effective atrial fibrillation treatment methods?
Atrial fibrillation (AF) is the most common type of cardiac arrhythmia affecting about 1% of the general population. Treatments such as rate controlling therapy… Read more »
Migraine—Are more effective treatments in sight?
Migraine is a largely inherited neurological disorder leading to a combination of symptoms including headache, visual and aural effects. As any long-time… Read more »
BioMed Central at NCRI 2009 and Sage bionetworks
Several members of the BioMed Central Editorial team had the pleasure of attending the annual conference held by the National Cancer Research Institute (NCRI)… Read more »
BMC Medicine talks about the future
In June 2009, BMC Medicine received its first “official” impact factor from Thomson Reuters of 3.28. To mark this landmark occasion, the BMC Medicine… Read more »
Modeling the spread of influenza infection — two new articles from BMC Medicine
When will the next wave of influenza A (H1N1) or “swine flu” infections occur, how quickly will they spread, and are there dangers of new emerging human… Read more »